|
|
|||||||||||||||||||||||
Article Navigation
|
Dr. Raymond Rife and His Miracle Machineby: Mark Rigney I'm willing to take a chance here and bet my next paycheck that you've never heard of Dr. Raymond Rife, nor of his amazing machines. Did I win? I thought so. Would you be surprised to learn that Dr. Rife developed a system, more than 70 years ago, which safely and quickly kills viruses, bacteria, Candida, fungus, parasites, and even cancer, with no side effects, and no toxicity? This remarkable technology was invented by a humble man, with no formal medical training, who not only realized that common pathogens could be literally "exploded" by submitting them to a resonant frequency (similar to the way a soprano can shatter a wine glass by singing the resonant frequency), but he also invented and machined a 5,300 part microscope which use polarized light to watch these microorganisms as they were annihilated. In 1934, the University of Southern California appointed a Special Medical Research Committee to bring 16 terminal cancer patients from Pasadena County Hospital to Rife's San Diego Laboratory and clinic for treatment. The team included doctors and pathologists assigned to examine the patients, if still alive, in 90 days. After the 3 months of treatment, the Committee concluded that 14 of the patients had been completely cured. The treatment was then adjusted and the remaining 2 also were cured within the next 4 weeks. On November 20, 1931, forty-four of the nation's most respected medical authorities honored Royal Rife with a banquet billed as "The End To All Diseases" at the Pasadena estate of Dr Milbank Johnson. But by 1939, almost all of these distinguished doctors and scientists were denying that they had ever met Rife. This complete reversal was the result of pressure from the drug companies on them. 'Pressure' is a very nice way of saying it. On the eve of a press conference to announce the results of the 1934 study on Rife's cancer therapy, Dr Milbank Johnson, former president of the Southern California AMA, was fatally poisoned and his papers "lost". Also, after a failed attempt by Morris Fishbein to buy the rights to Rife's healing instrument for the medical drug industry, Rife's labs were destroyed by arson and sabotage. Dr. Nemes, who had duplicated some of the work of Rife, was killed in a mysterious fire which destroyed all his research papers. A similar fire also destroyed the Burnett Lab, which was validating Rife's work. Royal Rife himself was killed in 1971 by an "accidental" lethal dose of Valium and alcohol at Grossmont Hospital. Participating in the original 1934 USC study were the following people: Director of the Northwestern Medical School Arthur Kendall, president of USC Rufus Klein-Schmidt, Milbank Johnson, Edward Kopps of the Metabolic Clinic in La Jolla, George Fischer of the NY Childrens Hospital, Kurt Meyer of the Hooper Foundation in San Francisco, and the Chief Surgeon of Santa Fe Railway Whalen Morrison. Dr Milbank Johnson, who was the professor of Physiology and Clinical Medicine at USC, and chairman of the Special Medical Research Committee, operated his own cancer clinic utilizing the Rife therapy for 10 years. He was able to document many cases of cancer reversal there. The United States medical establishment has not been particularly receptive to Dr. Rife's research since then, in spite of the numerous anecdotal cases of complete cancer remission, as well as full remission from hundreds of other symptoms, from auto-immune disorders to tuberculosis. Latest Cancer News:FDA panel votes against Xgeva for prostate cancer A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... A Better Way to Spend Breast Cancer Funds? We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Breast Cancer Drug May Weaken Bones, Study Finds TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marc Garnick Answers 6 Key Questions about Prostate Cancer Marc Garnick Answers 6 Key Questions about Prostate Cancer Breast cancer kills older women more often - Fox News
|
||||||||||||||||||||||